Medicine Man Technologies Inc (MDCL) Growth Rates Comparisons to Consulting Services Industry, Sector, Market. Sales, Income, EPS
CSIMarket Company Name, Ticker, Customers, else..
 
Medicine Man Technologies inc   (MDCL)
    Sector • Services    Industry • Consulting Services
   Industry • Consulting Services
   Sector • Services
 

Medicine Man Technologies Inc Growth Comparisons

Select each growth Category to receive further Information




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MDCL Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q4 MRQ) 7.91 % 9.97 % 2.34 % 1.01 %
Q / Q Revenue Growth (Q4 MRQ) -15.49 % -1.09 % 1.3 % 1.24 %
Y / Y Revenue Growth (for 12 months ending Q4 TTM) 10.7 % 11.88 % 10.96 % %
Sequential Revenue Growth (for 12 months ending Q4 TTM) 1.85 % 2.34 % 7.31 % 0.33 %
Revenue 5 Year Average Growth 78.69 % 8.69 % 6.5 % 7.23 %


MDCL's Growth Comparisons in IV. Quarter 2023




Medicine Man Technologies Inc 's Revenue slowed to the 7.91% year on year, improvement in the fourth quarter 2023 to 43 millions, underperforming the 9.97% growth in the Consulting Services industry, but beating the 2.34% growth in the Services sector. Above the average sales gains in the Services and in the Consulting Services industry as well, helped to elevate overall market growth to 1.01%.

Comparing company's Revenue to the third quarter results, sales were lower by -15.49% . On the annual basis, average annual sales growth for Medicine Man Technologies Inc is 78.69%, while S & P 500's including only Businesses with the fourth quarter 2023 results, average yearly sales growth is 7.23% over the past five years.


Growth Rates of MDCL's Income in the fourth quarter 2023


MDCL Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q4 MRQ) - 63.41 % 91.62 % 2.01 %
Sequential Operating Income Change (Q4 MRQ) - -20.95 % -27.04 % -4.59 %
Y / Y Operating Income Growth (Q4 TTM) -95.59 % 9.68 % 44.41 % -4.4 %
Sequential Operating Income Growth (Q4 TTM) -96.22 % 10.98 % 30.66 % -0.46 %
Operating Income 5 Year Avg. Change - 50.61 % 9.27 % 8.94 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q4 MRQ) - 205.95 % 115.7 % 6.55 %
Sequential Income from Cont. Ops. Change (Q4 MRQ) 490.86 % 2.12 % -75.13 % -13.27 %
Y / Y Income from Cont. Ops. Change (Q4 TTM) - 15.17 % 83.39 % -1.21 %
Sequential Income from Cont. Ops. Change (Q4 TTM) - 24.34 % 42.87 % 1.89 %
Income from Cont. Ops. 5 Year Avg. Change - 5.33 % 1.44 % 6.24 %

MDCL Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q4 MRQ) - 215.18 % - 2.53 %
Q / Q Net Income Growth (Q4 MRQ) - -8.88 % -75.68 % -19.48 %
Y / Y Net Income Change (Q4 TTM) - 15.17 % 68.04 % -0.13 %
Sequential Net Income Change (Q4 TTM) - 24.34 % 39.46 % 0.95 %
Net Income 5 Year Avg. Growth - 5.28 % -0.59 % 5.47 %

MDCL's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q4 MRQ) - 196.4 % 115.7 % 6.55 %
Sequential EPS from Cont. Ops. Change (Q4 MRQ) - 3.35 % -75.13 % -13.27 %
Y / Y EPS from Cont. Ops. Change (Q4 TTM) - -7.44 % - -
Sequential EPS from Cont. Ops. Change (Q4 TTM) - -7.91 % - 0 %
EPS from Cont. Ops. 5 Year Avg. Growth - -26.13 % 1.44 % 6.24 %



MDCL EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q4 MRQ) - 205.34 % - 6.24 %
Q / Q EPS Net Growth (Q4 MRQ) - -7.78 % -75.68 % -19.48 %
Y / Y EPS Net Change (for 12 months ending Q4 TTM) - -6.86 % - 38439.69 %
Sequential EPS Net Change (for 12 months ending Q4 TTM) - -7.52 % - 0.03 %
EPS Net 5 Year Avg. Change - 5.28 % -0.59 % 5.47 %



Medicine Man Technologies Inc reported bottom-line of $ 0.02 in the fourth quarter, compare to $ -0.69 in the same quarter a year ago. Consulting Services industry grew by 205.34%, while Services sector increased by 2.34%, and overall market improved by 2.53%.

Comparing the company's EPS to the third quarter results, income per share were lower by -15.49% . On the annual basis, average annual income per share growth for Medicine Man Technologies Inc is 78.69%, while S & P 500's including only Businesses with the fourth quarter 2023 financial reports, average yearly income per share growth is 5.47% over the past five years.

MDCL Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q4 MRQ) -20.09 % 7.24 % -6.89 % -5.16 %
Sequential Free Cash Flow Change (Q4 MRQ) 49.7 % 240.98 % -29.66 % -4.82 %
Y / Y Free Cash Flow Change (Q4 TTM) - -7.19 % 94 % 4.99 %
Sequential Free Cash Flow Change (Q4 TTM) -15.33 % 20.03 % 54.74 % 5.63 %
Free Cash Flow 5 Year Avg. Change 4.58 % 22.6 % 11.73 % 8.95 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q4 MRQ) - - - -
Sequential Net Cash Flow Change (Q4 MRQ) - -61.96 % - -
Y / Y Net Cash Flow Change (Q4 TTM) - - - -
Sequential Net Cash Flow Change (Q4 TTM) - - 10093.65 % 524.43 %
Net Cash Flow 5 Year Avg. Change - 8.55 % 8.31 % -33.51 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q4 MRQ) 156.83 % -7.56 % -9.15 % -10.32 %
Sequential Capital Expenditures Change (Q4 MRQ) - 5.79 % 8.55 % -0.97 %
Y / Y Capital Expenditures Change (Q4 TTM) -28.34 % 21.89 % 49.24 % 30.83 %
Sequential Capital Expenditures Change (Q4 TTM) 51.53 % 2.07 % 40.84 % 35.84 %
Capital Expenditures 5 Year Avg. Change - 4.84 % 11.12 % 8.85 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.